SAN FRANCISCO—Orteronel — a non-steroidal selective inhibitor of 17,20-lyase — did not achieve a significant improvement in overall survival in 1099...
NEW ORLEANS—A new oral tyrosine kinase inhibitor drug — idelalisib — has proved effective — and to have low toxicity — in patients with chronic...
The rare, fatal lympho-proliferative condition: Multicentric Castleman’s Disease — MCD — could soon be treatable following findings announced...
NEW ORLEANS—High remission rates with extended survival are being achieved in patients who had failed all other therapies — including allogeneic stem...
AudioMedica News Healthcare Delivery And Spending: Big Impact On Cancer Survival Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x...
AudioMedica News Global Handwashing Day!; Sex and Health; More Prisoners: More TB; How to Survive Cancer Play Episode Pause Episode Mute/Unmute...
AudioMedica News Audio Journal of Oncology Volume 16 Number 11 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30...
AudioMedica News Audio Journal of Oncology Volume 16 Number 10 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30...
AudioMedica News Audio Journal of Oncology Volume 16 Number 9 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30...
AudioMedica News Audio Journal of Oncology Volume 16 Number 8 Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30...
AudioMedica News Risks From Stopping Cancer Trials Early! Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds...
AudioMedica News Debate: Adjuvant Chemotherapy Should Be Standard in Stage I Non-Small Cell Lung Cancer Play Episode Pause Episode Mute/Unmute...